Off-label drug promotion and the First Amendment

Doctors can and often do prescribe medications for different purposes than what the FDA has approved them for. But drug companies face tight restrictions on communicating with physicians about these so-called “off-label” uses. If the pharmaceutical industry has its way, those restrictions may soon ease. Such a change would be healthy overall. Drugs undergo clinical [...]

Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/Qd5v0yYuzEE/

arab health health sciences institute